Internal medicine full syllabus and strategy
NEXT exam India internal medicine syllabus 2024 2025
NEXT India NExT exam internal medicine high yield topics strategy
NEXT exam internal medicine syllabus topics pattern
| Feature | Detail |
|---|---|
| Exam | National Exit Test (NExT) |
| Step 1 | Theory - MCQs (before internship) |
| Step 2 | Clinical/Practical (after internship) |
| Focus | CBME - clinical application, NOT pure recall |
| Replaces | NEET PG + FMGE |
| Pattern | Application-based, integrated, clinically oriented |
| Topic | Key Areas |
|---|---|
| Ischemic Heart Disease | ACS (STEMI/NSTEMI/UA), management algorithms, thrombolytics vs PCI, TIMI score |
| Heart Failure | HFrEF vs HFpEF, NYHA classification, drugs (ARNI, SGLT2i, BB, ACEi), acute pulmonary edema management |
| Hypertension | JNC 8 / ISH guidelines, resistant HTN, hypertensive emergencies, drug of choice in specific conditions |
| Arrhythmias | AF management (rate vs rhythm control, anticoagulation - CHA2DS2-VASc), VT/VF, complete heart block |
| Valvular Heart Disease | Mitral stenosis (most common RHD in India), MS area classification, surgical indications |
| Infective Endocarditis | Duke criteria, organisms, antibiotic prophylaxis |
| Pericardial Disease | Pericarditis, tamponade (Beck's triad), constrictive pericarditis |
| Aortic Dissection | DeBakey / Stanford classification, management |
| Peripheral Vascular Disease | ABI, critical limb ischemia |
| Topic | Key Areas |
|---|---|
| COPD | GOLD staging, exacerbation management, bronchodilators (LABA/LAMA), NIV criteria |
| Asthma | GINA stepwise therapy, status asthmaticus, severity classification |
| Pneumonia | CAP vs HAP vs VAP, CURB-65, organisms by setting, antibiotic choice |
| Tuberculosis | RNTCP/NTEP regimen (2HRZE/4HR), drug resistance (MDR/XDR-TB), DOTS, DRTB drugs |
| Pleural Effusion | Light's criteria (exudate vs transudate), causes, investigation |
| Pulmonary Thromboembolism | Wells score, D-dimer, CTPA, anticoagulation (DOAC vs heparin) |
| Interstitial Lung Disease | UIP (IPF), NSIP, sarcoidosis |
| Lung Cancer | Types, paraneoplastic syndromes, Lambert-Eaton, SIADH |
| Sleep Apnea | OSA - CPAP indications, Epworth scale |
| Pneumothorax | Spontaneous vs secondary, management |
| Topic | Key Areas |
|---|---|
| Peptic Ulcer Disease | H. pylori eradication, NSAID-induced, complications |
| GERD | Diagnosis, PPI use, Barrett's esophagus |
| Liver Disease | Child-Pugh / MELD score, cirrhosis complications (ascites, SBP, HRS, HE, variceal bleed) |
| Hepatitis | Viral hepatitis (A/B/C/D/E) - serology interpretation, treatment (HBV - tenofovir; HCV - sofosbuvir-based) |
| Inflammatory Bowel Disease | UC vs Crohn's - differences, extraintestinal manifestations, treatment |
| Pancreatitis | Ranson's criteria, Atlanta classification, management |
| GI Bleeding | Upper vs lower, causes, management |
| Malabsorption | Celiac disease (anti-tTG, HLA-DQ2/DQ8), tropical sprue |
| Jaundice | Pre-hepatic/hepatic/post-hepatic workup |
| Colorectal Cancer | Screening, FAP, Lynch syndrome |
| Topic | Key Areas |
|---|---|
| AKI | KDIGO staging, causes (pre/intra/post-renal), management, indications for dialysis (AEIOU) |
| CKD | GFR staging, complications, anemia of CKD, renal osteodystrophy, preparation for RRT |
| Glomerulonephritis | Nephrotic vs nephritic syndrome - diseases in each, cause-specific treatment |
| Nephrotic Syndrome | MCD (children - steroids), FSGS, membranous nephropathy (PLA2R antibody), DM nephropathy |
| Nephritic Syndrome | Post-streptococcal GN, IgA nephropathy (Berger's disease), RPGN |
| Hypertensive Nephropathy | |
| Tubular Disorders | RTA types (1,2,4), Fanconi syndrome |
| Renal Calculi | Types, investigation (NCCT), metabolic workup, management |
| Electrolyte Disorders | Hypo/hypernatremia, hypo/hyperkalemia, calcium, phosphate, magnesium |
| Dialysis | HD vs PD, indications |
| Topic | Key Areas |
|---|---|
| Diabetes Mellitus | T1 vs T2, diagnostic criteria, HbA1c targets, insulin types, OHA mechanisms (SGLT2i, GLP-1 RA, DPP4i), complications |
| Diabetic Emergencies | DKA vs HHS - differences, management |
| Thyroid Disorders | Hypothyroidism (TSH targets), hyperthyroidism (Graves' - TRAb, treatment), thyroid crisis, sick euthyroid |
| Thyroid Nodule/Cancer | FNAC, Bethesda system, papillary (most common) |
| Adrenal Disorders | Cushing's syndrome (workup - UFC, LDDST, HDDST), Addison's disease, Conn's syndrome (primary hyperaldosteronism), pheochromocytoma |
| Pituitary | Acromegaly (IGF-1, OGTT suppression), prolactinoma (dopamine agonist), Sheehan's syndrome, DI |
| Calcium Disorders | Primary hyperPTH, hypoparathyroidism, osteoporosis (DEXA, T-score) |
| Metabolic Syndrome | IDF/ATP III criteria |
| Obesity | BMI classification, management |
| PCOS | Rotterdam criteria, treatment |
| Topic | Key Areas |
|---|---|
| Anemias | Iron deficiency (Mentzer index), B12/folate deficiency, hemolytic anemias (Coombs test), aplastic anemia |
| Hemolytic Anemias | G6PD deficiency, hereditary spherocytosis, PNH, AIHA, sickle cell |
| Thalassemia | Alpha vs beta thal, management, prenatal diagnosis |
| Coagulation Disorders | Hemophilia A/B, vWD (types), DIC (lab pattern), ITP vs TTP |
| Transfusion Medicine | Compatibility, reactions (hemolytic, febrile, anaphylactic), massive transfusion |
| Leukemias | ALL vs AML vs CLL vs CML - key features, Philadelphia chromosome, BCR-ABL, imatinib |
| Lymphomas | Hodgkin's (Reed-Sternberg, ABVD) vs Non-Hodgkin's |
| Myeloma | Diagnostic criteria (CRAB), M-spike, bone lesions |
| Myeloproliferative Disorders | PV, ET, MF - JAK2 mutation |
| Thrombophilia | Factor V Leiden, APS (criteria, treatment) |
| Topic | Key Areas |
|---|---|
| Stroke | Ischemic vs hemorrhagic, thrombolysis (tPA - 4.5 hour window, contraindications), NIHSS |
| Epilepsy | Seizure classification, drug of choice by seizure type, status epilepticus management |
| Headache | Migraine (triptans), cluster headache, tension-type |
| Dementia | Alzheimer's (most common), Lewy body, FTD, vascular - features |
| Movement Disorders | Parkinson's disease (dopaminergic therapy, TRAP), essential tremor |
| Multiple Sclerosis | Relapsing-remitting, McDonald criteria, DMDs |
| Meningitis | Bacterial vs viral - CSF findings, empiric treatment |
| Peripheral Neuropathy | GBS (cytoalbuminous dissociation), Charcot-Marie-Tooth, mononeuritis multiplex |
| Neuromuscular | MG (anti-AChR, Tensilon test, thymoma), Lambert-Eaton |
| CNS Infections | Tuberculous meningitis (ADA in CSF), neurocysticercosis, cerebral malaria |
| Topic | Key Areas |
|---|---|
| Malaria | P. falciparum (severe malaria criteria - WHO 2015), treatment (ACT), chloroquine resistance |
| Typhoid | Widal (limitations), culture gold standard, drug of choice (azithromycin/ciprofloxacin), complications |
| Dengue | NS1/IgM, warning signs, management (no platelet <10k), grades |
| Leptospirosis | Weil's disease, conjunctival suffusion, penicillin |
| Kala-azar (VL) | rK39, splenomegaly, treatment (liposomal AmB) |
| Scrub Typhus | Eschar, Orientia, doxycycline |
| HIV/AIDS | CD4 staging, ART (NACO guidelines - TLD regimen), OIs by CD4 count |
| COVID-19 | Complications, management principles |
| Meningococcemia | Waterhouse-Friderichsen |
| Rickettsial Diseases | Rocky Mountain spotted fever, doxycycline |
| Topic | Key Areas |
|---|---|
| Rheumatoid Arthritis | ACR/EULAR criteria, DMARD choice (MTX first line), biologic agents |
| SLE | ACR criteria, ANA/anti-dsDNA/anti-Sm, lupus nephritis, SLEDAI |
| Seronegative SpA | AS (HLA-B27), PsA, ReA, IBD-related - differences |
| Crystal Arthropathies | Gout (urate-lowering: allopurinol/febuxostat), pseudogout (CPPD) |
| Vasculitides | GCA (temporal artery biopsy, ESR), Takayasu, PAN (HBV-assoc.), Wegener's/GPA (c-ANCA) |
| Scleroderma | Limited (CREST, anti-centromere) vs diffuse (anti-Scl-70), SSc lung |
| Myositis | PM/DM - anti-Jo-1, proximal weakness, skin findings in DM |
| Antiphospholipid Syndrome | Recurrent thrombosis/miscarriage, lupus anticoagulant |
| Sjögren's | Anti-SSA/SSB, sicca syndrome |
| Topic | Key Areas |
|---|---|
| Systemic disease skin manifestations | Acanthosis nigricans (IR/DM), pyoderma gangrenosum (IBD), erythema nodosum |
| Drug rashes | SJS/TEN (causes: sulfa, allopurinol, AEDs), DRESS syndrome |
| Autoimmune skin | Pemphigus vs pemphigoid |
| Topic |
|---|
| Sepsis (Sepsis-3 criteria, qSOFA, SOFA) |
| ARDS (Berlin criteria, P/F ratio, prone positioning) |
| Mechanical ventilation basics |
| Shock types (distributive/cardiogenic/hypovolemic/obstructive) |
| Poisoning (organophosphate, paracetamol, iron, CO) |
| Electrolyte emergencies |
| Priority | Topics |
|---|---|
| MUST DO | Cardiology (ACS/HF/HTN), Diabetes + thyroid, Hepatitis + cirrhosis, TB (NTEP), HIV (NACO), AKI/CKD, Anemia types, Dengue/malaria/typhoid, Stroke |
| HIGH YIELD | Nephrotic/nephritic syndrome, COPD/Asthma, SLE, Leukemia/lymphoma, GBS, Hemophilia, Sepsis |
| MODERATE | IBD, Vasculitis, Interstitial lung disease, Pituitary disorders, Myeloma, Parkinson's |
| LOW YIELD (do last) | Rare metabolic disorders, esoteric enzyme deficiencies, individual drug pharmacokinetics |
| Purpose | Book |
|---|---|
| Primary theory | Davidson's Medicine (26th ed) OR Harrison's (selected chapters) |
| Quick revision | APICP Manual of Medicine OR Medicine Recall |
| MCQ practice | DAMS previous papers + Marrow/Prepladder Qbank |
| Notes/Mnemonics | Own notes + Rohan Khandelwal's IM notes |
| ECG | ECG Made Easy by John Hampton |
| Images | Sobotta Atlas + CBT image gallery |
| Day | Morning (3h) | Evening (2h) | Night (1.5h) |
|---|---|---|---|
| Mon | Theory reading (new topic) | MCQ practice (same topic) | Revision of yesterday |
| Tue | Theory reading | MCQ practice | Previous year Qs |
| Wed | Theory reading | MCQ practice | Short notes making |
| Thu | Revision (weak areas) | MCQ practice | Integration questions |
| Fri | New topic | MCQ practice | Tables/comparisons |
| Sat | Full-length mock test | Test analysis | Error correction |
| Sun | Weak area deep dive | Light MCQs | Weekly notes review |